Natuzzi Filed Its Annual Report on Form 20-F With the SEC

SANTERAMO IN COLLE, Bari, Italy--(BUSINESS WIRE)-- Natuzzi S.p.A. (NYSE: NTZ) (“Natuzzi” or the “Company”) announced today that it filed its annual report on Form 20-F (the “Annual Report”) for the fiscal year ended on December 31, 2021 with the U.S. Securities and Exchange Commission (“SEC”). The Annual Report is available on the Company’s website www.natuzzi.com within the Investor Relations page (http://natuzzigroup.com/en-EN/ir/investors.html), under the “SEC Filings” section.

The Company’s shareholders can request a hard copy of the Annual Report, which includes the audited consolidated financial statements, free of charge, by contacting the Company at [email protected].

About Natuzzi S.p.A.

Founded in 1959 by Pasquale Natuzzi, Natuzzi S.p.A. is one of the most renowned brands in the production and distribution of design and luxury furniture. With a global retail network of 651 mono-brand stores and 563 galleries as of December 31, 2021, Natuzzi distributes its collections worldwide. Natuzzi products embed the finest spirit of Italian design and the unique craftmanship details of the “Made in Italy”, where a predominant part of its production takes place. Natuzzi has been listed on the New York Stock Exchange since May 13, 1993. Always committed to social responsibility and environmental sustainability, Natuzzi S.p.A. is ISO 9001 and 14001 certified (Quality and Environment), ISO 45001 certified (Safety on the Workplace) and FSC® certified (Forest Stewardship Council).

View source version on businesswire.com: https://www.businesswire.com/news/home/20220502005543/en/

For information:
Natuzzi Investor Relations
James Carbonara | tel. +1 (646)-755-7412 | [email protected]
Piero Direnzo | tel. +39 080-8820-812 | [email protected]

Natuzzi Corporate Communication
Giacomo Ventolone (Press Office) | tel. +39.335.7276939 | [email protected]

Source: Natuzzi S.p.A.

You May Also Be Interested In

• Redwoods Acquisition (RWOD) stockholders approve proposals
• Soligenix, Inc. (SNGX) Prices $4.75 Million Public Offering
• Benitec Biopharma (BNTC) Announces $40M Placement at $4.80/sh